Home › Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock
 

Keywords :   


Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

2014-12-09 11:06:42| Biotech - Topix.net

After spending $19 billion on 40 acquisitions since 2008, the Canadian drugmaker is regrouping after failing last month to acquire Botox-maker Allergan Inc ( The new strategy, targeted for the next two to three quarters, may surprise some investors accustomed to Valeant's usual way of doing business. Speculation about Valeant's next takeover target has driven up shares in generic drugmaker Mylan Inc ( Valeant does not rule out pursuing deals where appropriate, but it is focused on its ability to pay down debt or buy back shares, said spokeswoman Laurie Little.

Tags: stock term cut drop

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
More »